BRAF
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Tunlametinib Combination Therapy in the Treatment of Second-line and Above Metastatic Colorectal Cancer (NCT07714447) | Sun Yat-sen University | 2026-11-30 |
| The Safety and Efficacy of Cetuximab Beta Plus Fruquintinib With or Without Immune Checkpoint Inhibitorrs in First-line Treatment of RAS/BRAF Wild Type Unresectable Metastatic Colorectal Cancer (NCT07257653) | Zhejiang University | 2025-10-21 |
| Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies (NCT05786924) | Institut de Recherches Internationales Servier | 2023-04-18 |
| Real-Time Monitoring of Symptoms in Lung Cancer Patients Receiving Oral Targeted Therapies (NCT05370469) | University of Virginia | 2022-08-25 |
Track BRAF automatically
Every clearance here is in the API, with alerts when new ones post.